New Delhi: Adar Poonawalla, CEO of the Serum Institute of India, the world’s largest vaccine manufacturer by volume and which is conducting trials of Covid vaccine candidates prior to mass production, took to Twitter today to highlight challenges in production and distribution. of vaccines in the country. “Quick question: Will …
Read More »
“It will take four to five years for everyone on this planet to get the vaccine,” Poonawalla told the Financial Times. The CEO of the world’s largest vaccine manufacturer has estimated that if the Covid-19 injection is a two-dose vaccine, like measles or rotavirus, the world will need 15 billion …
Read More »
Adar Poonawalla, executive director of the Serum Institute of India (SII), has warned that there will not be enough vaccines against the coronavirus disease (Covid-19) for everyone in the world until the end of 2024, according to a report Monday. . The CEO of the world’s largest vaccine manufacturer has …
Read More »
A research scientist works inside a laboratory at the Serum Institute in India, the world’s largest vaccine manufacturer, working on vaccines against the coronavirus disease (COVID-19) in Pune. (Image used for representation: Reuters) The Pune-based company halted trials on Thursday, saying it would review the situation and wait for pharmaceutical …
Read More »
NEW DELHI: India’s central drug regulator issued a notice to the Pune-based Serum Institute of India (SII) on Wednesday, asking why the company had failed to inform it of the “reported serious adverse events” that led to UK partner AstraZeneca to “temporarily pause” global clinical trials of the Oxford Covid …
Read More »
NEW DELHI: Clinical trials for the Covid-19 candidate vaccine developed by the University of Oxford, which were expected to begin at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, have been delayed for at least a week. Trials that were expected to begin in the first week …
Read More »
Coronavirus Vaccine Agreement: Bangladesh’s Beximco said it will invest in Serum India Ltd representative) Calcutta: As the race for a COVID-19 vaccine intensifies, Bangladesh’s leading pharmaceutical company, Beximco, has announced that it will invest in Adar Poonawalla’s Serum India Limited (SIL) for the development of the vaccine. The size of …
Read More »